Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2024-02-12 00:00:00 ET · period of report 2024-02-08 · accession 0000950170-24-013817 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-12 | 2024-02-08 | IRWD | Emany Sravan Kumar | SVP, CFO | F - Tax | $14.90 | -41.3K | 225.7K | -15% | -$615.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-02-08 | F | D | 41,332 | $14.90 | 225,737 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units and restricted stock units. |